TRI-LUMA

This page contains recent news articles, when available, and an overview of TRI-LUMA but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Overview:

TRI-LUMA (when available)

Pharmacology and use:
Tretinoin, also known as all-trans-retinoic acid (ATRA), is a naturally occurring derivative of vitamin A (retinol). Retinoids such as tretinoin are important regulators of cell reproduction, proliferation, and differentiation and are used to treat acne and photodamaged skin and to manage keratinization disorders such as ichthyosis and keratosis follicularis. Tretinoin also represents the class of anticancer drugs called differentiating agents and is used in the treatment of acute promyelocytic leukemia (APL). For the the induction of remission in patients with acute promyelocytic leukemia (APL), French-American-British (FAB) classification M3 (including the M3 variant); For the topical treatment of acne vulgaris, flat warts and other skin conditions (psoriasis, ichthyosis congenita, icthyosis vulgaris, lamellar icthyosis, keratosis palmaris et plantaris, epidermolytic hyperkeratosis, senile comedones, senile keratosis, keratosis follicularis (Darier's disease), and basal cell carcinomas.); For palliative therapy to improve fine wrinkling, mottled hyperpigmentation, roughness associated with photodamage.

Mechanism Of Action:
Tretinoin binds to alpha, beta, and gamma retinoic acid receptors (RARs). RAR-alpha and RAR-beta have been associated with the development of acute promyelocytic leukemia and squamous cell cancers, respectively. RAR-gamma is associated with retinoid effects on mucocutaneous tissues and bone. Although the exact mechanism of action of tretinoin is unknown, current evidence suggests that the effectiveness of tretinoin in acne is due primarily to its ability to modify abnormal follicular keratinization. Comedones form in follicles with an excess of keratinized epithelial cells. Tretinoin promotes detachment of cornified cells and the enhanced shedding of corneocytes from the follicle. By increasing the mitotic activity of follicular epithelia, tretinoin also increases the turnover rate of thin, loosely-adherent corneocytes. Through these actions, the comedo contents are extruded and the formation of the microcomedo, the precursor lesion of acne vulgaris, is reduced. Tretinoin is not a cytolytic agent but instead induces cytodifferentiation and decreased proliferation of APL cells in culture and in vivo. When Tretinoin is given systemically to APL patients, tretinoin treatment produces an initial maturation of the primitive promyelocytes derived from the leukemic clone, followed by a repopulation of the bone marrow and peripheral blood by normal, polyclonal hematopoietic cells in patients achieving complete remission (CR). The exact mechanism of action of tretinoin in APL is unknown.

News Articles on Tretinoin

Dan otra lista crema pudo blanquear la piel de Sosa  -  14 Nov 2009
Clasifel, Avitil, Diroseal, Neostrata, Phyto Spot, Tri-Luma, Unitone y Eucerin fluidos despigmentantes, cuyas posologías destacan las propiedades para ... El Nacional (República Dominicana)

Three Cetaphil(R) Products Earn Good Housekeeping Seal  -  ‎Oct 19, 2009‎
Leading worldwide dermatology brands include Differin®, Epiduo(TM), Oracea®, MetroGel® 1%, Rozex®, Clobex®, Vectical(TM), Tri-Luma®, Loceryl® and Cetaphil®. ... Reuters

Loislaw Federal District Court Opinions - HAUGHTON v. HILL …  -  Aug 30, 2007
HAUGHTON v. HILL LABORATORIES, INC. (Mass. 8-30-2007) PATRICIA HAUGHTON v. HILL LABORATORIES, INC. CIVIL ACTION No. 06-11217-RGS. ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw

Melasma is prevalent across many racial groups.(Clinical Rounds)( …  -  Apr 1, 2006
PARK CITY, UTAH -- Melasma is a chronic, relapsing condition occurring across racial groups, Dr. Susan C. Taylor said at a clinical dermatology seminar ... Free with registration - OB GYN News - AccessMyLibrary.com

Galderma announces approval for Differin(R) Gel 0.1% in Japan  -  Jul 17, 2008
Lausanne (ANTARA News/PRNewswire-AsiaNet) - Galderma Pharma SA, a global specialty pharmaceutical company focused on dermatology, announced today that ... ANTARA

Galderma Announces Approval for Differin(R) Gel 0.1% in Japan  -  Jul 16, 2008
Galderma Pharma SA, a global specialty pharmaceutical company focused on dermatology, announced today that Japan's Ministry of Health, Labor and Welfare has ... Bloomberg

Hydroquinone.(Cosmeceutical Critique)  -  Feb 1, 2007
With a track record of safety and efficacy spanning more than 40 years, hydroquinone, a hydroxyphenolic derivative of benzene, is considered the most ... Free with registration - Skin & Allergy News - AccessMyLibrary.com

Press Release: Galderma Introduces Larger 4.25 Ounce Bottle of …  -  Jan 17, 2007
Galderma Introduces Larger 4.25 Ounce Bottle of CLOBEX(R) Spray for the Treatment of Moderate-to-Severe Plaque Psoriasis. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research

Press Release: Cetaphil(R) Survey Suggests Smooth, Moisturized Skin …  -  May 24, 2006
Cetaphil(R) Survey Suggests Smooth, Moisturized Skin Makes Significant Other's Hearts Go Pitter Patter. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research

Pigment problems solved  -  May 15, 2007
Many prescription topical treatments such as Tri-Luma combine lightening agents (in this case, ... Tri-Luma also includes a steroid to minimize irritation. ... Scripps News - Scripps News

Private view. | Article from Medical Marketing & Media | HighBeam …  -  Dec 1, 2008
...pasteur Travelers Sales Aid [ILLUSTRATION OMITTED] The agency sought to raise ... Pharm and Galderma for Tri Luma Cream Visual Aid * Corbett and Alcon . ... Pay-Per-View - Medical Marketing & Media - HighBeam Research

Private view.  -  Dec 1, 2008
Private view. You're launching a terrific new product. It trumps the competition in every way; it's loaded with innovative features and benefits; ... $9.94 - Medical Marketing & Media - Alacra Store

Press Release: FDA Approves Differin(R) (adapalene) Gel, 0.3% for...  -  Jun 20, 2007
FDA Approves Differin(R) (adapalene) Gel, 0.3% for Acne. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research

Galderma 宣佈Differin(R) Gel 0.1% 在日本�?�准使用基於日本有�?�以來最大 …  -  Jul 17, 2008
...瑞士洛桑, 7月17日/新�?�美通/ -- 全�?�皮膚醫學專業制藥公�?�Galderma Pharma SA 今天宣佈，日本厚生勞動�?已經批准在日本使用一種�?�?痤瘡的新型局部治療 ... 財�?�網

Time to Take Stock After a Season in the Sun  -  Sep 7, 2006
By NICK BURNS. THE last long summer weekend has passed and fall is just a few cooling weeks away. But long after the sweet summer days are behind us, ... New York Times

Pharmaceutical firm SkinMedica files to sell shares in public...  -  Apr 28, 2005
Apr. 28--Cosmetic skin care company SkinMedica moved yesterday to test the tepid financial market by registering to raise up to $86.2 million in an initial ... Free with registration - San Diego Union - Tribune - AccessMyLibrary.com

바른언론 빠른뉴스 �?�터넷 연합뉴스  -  Mar 8, 2008
...(로잔 3월 8�?� AsiaNet= 연합뉴스) Galderma Pharma, SA는 국소 마취�?�림�?� 플리아글 리스�?� �?촉과 배�?� �?��?권�?� 미국과 �?나다 �?�외�?� 지역�?서�?� 갖�?��? 하는 �?스 ... 연합뉴스

Fair game for cosmetics companies: Skin whiteners  -  Sep 15, 2005
Some whiteners contain hydroquinone, the same active ingredient used in prescription-strength spot-removing creams, such as Lustra, Tri-Luma and EpiQuin ... Pay-Per-View - Orlando Sentinel - ProQuest Archiver

YOUR BOD, BABE! OUT, DAMNED SPOT! Uneven skin color and tone …  -  Nov 2, 2006
BY JULIAN KESNER. Just ask Rebecca Brown, a 32-year-old bank exec who has melasma, a skin pigment abnormality. "I was really embarrassed about the dark ... New York Daily News

Darker skin a shield, yet can be vulnerable  -  Jun 17, 2007
This advice may seem strange to those whose dark skin pigment greatly decreases their risk of skin cancer. "Many ethnic individuals have never put on ... Pay-Per-View - Chicago Tribune - ProQuest Archiver

Galderma Pharma， SA 和ZARS Pharma， Inc. 拓展�??议以覆盖Pliaglis …  -  Mar 10, 2008
...新�?�美通瑞士洛桑3月10日电：Galderma Pharma, SA 宣布与ZARS Pharma, Inc. 达�?�??议，Galderma 将获得一�?新型局部麻醉乳剂在美国和加拿大外所有市场的独家推广�?�和 ... 金�?界

新�?�美通消�?�：Galderma 完�?对CollaGenex 的收购�?约  -  Apr 8, 2008
...瑞士洛桑2008年4月7日电/新�?�美通/ -- 专注于皮肤医学的全�?�特�?�?��?公�?�Galderma Pharma SA 今天宣布，该公�?�美国控股公�?�Galderma Laboratories, Inc. 已�?完�?其 ... �?券之星

Dermatologist can lighten unsightly skin discoloration  -  Oct 1, 2005
Do you have dark, patchy discoloration on your cheeks, forehead, jaw line or around the mouth? If so, you might have melasma, a skin condition that affects ... Youngstown Vindicator

Galderma 宣布其收购CollaGenex Pharmaceuticals 的�??议获得HSR 许�?�  -  Mar 20, 2008
...新�?�美通瑞士洛桑3月20日电：致力于皮肤医学的全�?�性特�?�?��?�?业Galderma Pharma SA 今天宣布，其美国控股公�?�Galderma Laboratories, Inc. 拟议的对CollaGenex ... 金�?界

Galderma 完�?�?CollaGenex 的收購  -  Apr 14, 2008
...瑞士洛桑, 4月14日/新�?�美通/ -- 專注於皮膚醫學的全�?�性專業制藥�?業Galderma Pharma SA 今天宣佈，該公�?�的美國控股公�?�Galderma Laboratories, Inc. 已完�?了 ... 財�?�網

ERASING BROWN PATCHES  -  Nov 13, 2007
Q: I'm developing brown patches on my cheeks and chin. Why -- and how can I make them go away? A: It sounds like you're describing a type of ... $2.95 - Miami Herald - NewsBank

The treatments .  -  Sep 8, 2005
Your dermatologist should be the first stop if you think you have melasma Once you are diagnosed correctly, you can start discussing treatment Your ... Times Daily - Google News Archive

Galderma 完�?�?CollaGenex 的收購�?約  -  Apr 7, 2008
...瑞士洛桑2008年4月7日電/新�?�美通/ -- 專注于皮膚醫學的全�?�特種藥�?公�?�Galderma Pharma SA 今天宣布，該公�?�美國控股公�?�Galderma Laboratories, Inc. 已經完�?其 ... 財�?�網

Anika Therapeutics Announces Worldwide Development and …  -  Jul 5, 2006
WOBURN, Mass., July 5 /PRNewswire-FirstCall/ -- Anika Therapeutics, Inc. today announced that it has signed an exclusive worldwide development and ... Free with registration - PR Newswire - AccessMyLibrary.com

SKIN DEEP: Get facts for clinical trials  -  Oct 2, 2007
Q: I was asked to participate in a clinical research trial. I'm afraid to be experimented on. What should I know? A: Every drug or device must go through a ... $2.95 - Miami Herald - NewsBank

Sunspot solutions.(Public Eye: ... What your patients are reading in...  -  Sep 1, 2005
...* Apply a skin-lightening cream such as prescription Tri-Luma, which contains the lightening agent hydroquinone; it works in three to four weeks. ... Free with registration - Dermatology Times - AccessMyLibrary.com

Universo Empresarial - eluniversal.com  -  Mar 3, 2008
Millones de mujeres sufren de manchas en el rostro, de color marrón o gris amarronadas, que son signos típicos del melasma. ... El Universal - El Universal (Venezuela)

Galderma to Present Corporate and Partnering Overview at the BIO 2006...  -  Apr 5, 2006
PARIS and FORT WORTH, Texas, April 5 /PRNewswire/ -- Galderma International SA today announced that Arthur Clapp, Vice President, Business Development at ... Free with registration - PR Newswire - AccessMyLibrary.com

Galderma Pharma, SA 和ZARS Pharma, Inc. 拓展�?�議以覆蓋Pliaglis(TM) …  -  Mar 10, 2008
...瑞士洛桑3月10日電/新�?�美通/ -- Galderma Pharma, SA 宣布與ZARS Pharma, Inc. �?��?�?�議，Galderma 將�?�得一種新型局部麻醉乳劑在美國和加拿大外所有市場的�?�家推廣權 ... 財�?�網

Galderma 宣布其收購CollaGenex Pharmaceuticals 的�??議�?�得HSR 許�?�  -  Mar 20, 2008
...致力于皮膚醫學的全�?�性特種藥�?�?業Galderma Pharma SA 今天宣布，其美國控股公�?�Galderma Laboratories, Inc. 擬議的�?CollaGenex (Nasdaq: CGPI) 的收購已經�?�得 ... 財�?�網

Article: Galderma launch.(Galderma Laboratories Inc. gets approval...  -  Aug 29, 2005
Galderma launch.(Galderma Laboratories Inc. gets approval for MetroGel)(Brief Article) ... find Chain Drug Review articles. Pay-Per-View - Chain Drug Review - HighBeam Research

Galderma Umumkan Obat Jerawat Differin(R) Gel 0,1% yang Disetujui di ...  -  Jul 17, 2008
Lausanne, 17 Juli (ANTARA/PRNewswire-AsiaNet) -- Galderma Pharma, SA, perusahaan farmasi global yang membidangi masalah dermatologi, mengumumkan hari ini ... ANTARA

Multimodal therapy: is more better? Potential multiple benefits in...  -  Oct 1, 2006
Miami -- While an evidence base is lacking to demonstrate benefits of combination treatment for melasma using topical plus procedural modalities, ... $4.95 - Dermatology Times - ECNext

Article: Skin of color may mask rosacea's classic signs: there are...  -  Jul 1, 2005
Skin of color may mask rosacea's classic signs: there are both topical and oral treatment options, but a combination approach is considered best. Pay-Per-View - Internal Medicine News - HighBeam Research

Galderma �?��?收購CollaGenex Pharmaceuticals 的�?�議  -  Feb 26, 2008
...瑞士洛桑和賓夕法尼亞州NEWTOWN 2月26日電/新�?�美通/ -- 致力于皮膚醫學的全�?�特種藥�?�?業Galderma Pharma SA 與CollaGenex Pharmaceuticals, Inc. (Nasdaq: CGPI) ... 財�?�網

More In Features  -  Jul 1, 2007
Eighteen months into a new brand identity, Brand Pharm—the agency formerly known as Nelson Communications—is humming along with a trio of assignments from ... Medical Marketing & Media - Medical Marketing and Media

Managing your melasma begins at the dermatologist  -  Sep 13, 2005
One of the latest prescriptions to fall into favor with dermatologists is Tri-Luma, which contains hydroquinone and tretinoin as well as a steroid to ... $3.50 - Intelligencer, The - NewsBank

Euro RSCG Life splits PR function, recruits Catlett.  -  Jul 1, 2006
Euro RSCG Life splits PR function, recruits Catlett. EURO RSCG LIFE has split its communications practice into product and corporate PR divisions, ... $9.94 - Medical Marketing & Media - Alacra Store

Products .Promos Galderma Sponsors Talk .  -  Jan 18, 2007
...business group, discussing trends in convergence and mobility during the conference. an IBM user organization is a non-stock, non-profit group with the main ... Manila Times - Google News Archive

Article: Skin of color may occlude rosacea's classic, clinical...  -  Mar 1, 2005
Skin of color may occlude rosacea's classic, clinical signs.(Dermatologic Therapy) ... find Skin & Allergy News articles. MIAMI BEACH -- Although considered ... Pay-Per-View - Skin & Allergy News - HighBeam Research

Article: Diamonds: a man's best friend?(NAME THAT BRAND) - Medical …  -  Dec 1, 2006
Diamonds: a man's best friend?(NAME THAT BRAND) ... find Medical Marketing & Media articles. Brand X should need no introduction. Pay-Per-View - Medical Marketing & Media - HighBeam Research

Galderma #1 In Image Survey Among Dermatological Health Care …  -  Jan 14, 2007
January 8, 2007 Galderma Laboratories, LP ranks number one in the eyes of dermatological health care professionals according to the latest Verispan ... Medical News Today - Medical News Today (press release)

Article: Hats off to a potential blockbuster.(NAME THAT BRAND) -...  -  Apr 1, 2005
Hats off to a potential blockbuster.(NAME THAT BRAND) ... find Medical Marketing & Media articles. Brand X was every medical journal publisher's favorite ... Pay-Per-View - Medical Marketing & Media - HighBeam Research

Press Release: Galderma to Present Corporate and Partnering Overview ...  -  Apr 5, 2006
Galderma to Present Corporate and Partnering Overview at the BIO 2006 Annual Meeting and Convention. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research

Galderma #1 in Image Survey; First Company in Six Years to Sweep All ...  -  Jan 8, 2007
FORT WORTH, Texas, Jan. 8 /PRNewswire/ -- Galderma Laboratories, LP ranks number one in the eyes of dermatological health care professionals according to ... Free with registration - PR Newswire - AccessMyLibrary.com

Galderma annonce l'autorisation du gel Differin(R) 0,1 % au Japon  -  Jul 17, 2008
LAUSANNE, Suisse, Galderma Pharma SA, société pharmaceutique internationale spécialisée en dermatologie, a annoncé aujourd'hui que le ministère de la santé, ... Caducée.net

COMUNICADO: Galderma finaliza la adquisición de CollaGenex (1)  -  Apr 13, 2008
Galderma Pharma SA, una compañía farmacéutica mundial especializada en dermatología, ha anunciado hoy que su compañía mixta, Galderma Laboratories, Inc., ... Cotizalia.com

COMUNICADO: Galderma anuncia la aprobación de Differin(R) Gel 0,1% …  -  Jul 17, 2008
Galderma Pharma SA, una compañía farmacéutica internacional especializada en dermatología ha anunciado hoy que el Ministro de sanidad, trabajo y bienestar ... Cotizalia.com

Galderma anuncia aprovação para Differin(R) Gel 0,1% no Japão  -  Jul 18, 2008
Lausanne, Suíça -A Galderma Pharma SA, uma empresa farmacêutica global especializada em dermatologia, anunciou que o Ministério da Saúde, ... Revista Fator

Brand X delivers a hammer blow.(NAME THAT BRAND) | Article from …  -  Oct 1, 2005
Brand X delivers a hammer blow.(NAME THAT BRAND) ... find Medical Marketing & Media articles. October's Brand X is one mature product that's still proving a ... Pay-Per-View - Medical Marketing & Media - HighBeam Research

Y Brand.(AGENCIES) | Article from Medical Marketing & Media | …  -  Apr 1, 2006
Y Brand.(AGENCIES) ... find Medical Marketing & Media articles. Y Brand has named Miles West SVP, customer insight planner. West joins Y Brand from Corbett ... Pay-Per-View - Medical Marketing & Media - HighBeam Research

Article: A not-so-familar ring to it.(NAME THAT BRAND) - Medical …  -  Aug 1, 2005
A not-so-familar ring to it.(NAME THAT BRAND) ... find Medical Marketing & Media articles. Brand X is a different kind of stork repellent in a crowded ... Pay-Per-View - Medical Marketing & Media - HighBeam Research

40 ads with bite: we asked numerous industry executives for their …  -  Oct 1, 2006
40 ads with bite: we asked numerous industry executives for their thoughts on the most memorable campaigns from the past four decades of medical advertising ... Pay-Per-View - Medical Marketing & Media - HighBeam Research

The anti-aging boom: even modest changes can revitalize, rejuvenate!  -  Dec 1, 2006
Mercifully, this process is slow and its effects are rarely seen overnight. But sometimes, this process of aging catches us by surprise. ... $4.95 - Dermatology Times - ECNext

Combination therapies best approach for melasma.(Special Report: …  -  Jul 1, 2007
National report--Wile the Food and Drug Administration's decision on whether to ban hydroquinone is still pending, dermatologists are searching for ... $4.95 - Dermatology Times - ECNext

PhotoCure ASA - Metvix approved in Brazil  -  Sep 15, 2005
PhotoCure ASA announces today that Metvix is approved in Brazil for the treatment of actinic keratosis (pre-cancerous skin lesions) and basal cell carcinoma ... Pay-Per-View - Hugin Press Release - Factiva, from Dow Jones

CollaGenex Being Acquired by Galderma for $420M Cash  -  Feb 27, 2008
By Catherine Hollingsworth. CollaGenex Pharmaceuticals Inc. said it has agreed to be acquired by a US affiliate of Galderma Pharma SA for about $420 million ... BioWorld Online - BioWorld Online

CollaGenex Pharmaceuticals Announces Expiration of the Hart-Scott- …  -  Mar 19, 2008
CollaGenex Pharmaceuticals, Inc. (NASDAQ:CGPI) today announced that the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of ... Genetic Engineering News - Genetic Engineering News (press release)

Getting Past the Pain of Common Cosmetic Procedures  -  Mar 26, 2008
FT. WORTH, TX--(Marketwire - March 26, 2008) - Demand for cosmetic procedures such as laser resurfacing, dermal filler injections and laser hair removal is ... marketwire.com

The Top 60: Brand Pharm  -  Jul 1, 2008
Many healthcare-focused agencies do back flips to portray themselves as “one-stop shops,�? even if their offerings in certain areas—the digital space, ... Medical Marketing & Media - Medical Marketing and Media

Euronext - Van genoteerde ondernemingen > Persberichten  -  Jul 4, 2008
DISCLAIMER: This release must not be diffused to any correspondent in one of the following countries: Australia, Canada, Japan. ... euronext.com

Banishing the bleach: FDA mulls hydroquinone rule; derms say concerns...  -  Jul 1, 2007
National report--While the Food and Drug Administration (FDA) ponders the future of hydroquinone, manufacturers and physicians continue to emphasize that no ... $4.95 - Dermatology Times - ECNext

Press Release: Results of Large Phase IV Study Show Differin(R) ( …  -  Mar 3, 2006
Results of Large Phase IV Study Show Differin(R) (adapalene gel) Gel, 0.1% Works Well in Combination With Systemic or Other Topical Agents. from PR Newswire ... Pay-Per-View - PR Newswire - HighBeam Research

Bourse, cours des actions, CAC 40 - La bourse en ligne - LCI -...  -  Apr 7, 2008
AVERTISSEMENT : Ce communiqué ne doit pas être diffusé à un correspondant situé dans l'un des pays suivants : Australie, Canada, Japon. ... TF1

Article: Conservatism aids C[O.sub.2] laser success in dark skin.( …  -  Feb 1, 2007
Conservatism aids C[O.sub.2] laser success in dark skin.(Dermatologic Surgery) ... find Skin & Allergy News articles. RHODES, GREECE -- C[O.sub.2] lasers ... Pay-Per-View - Skin & Allergy News - HighBeam Research

Bourse en ligne, actualité des cours de la bourse en ligne avec LCI  -  Feb 26, 2008
AVERTISSEMENT : Ce communiqué ne doit pas être diffusé à un correspondant situé dans l'un des pays suivants : Australie, Canada, Japon. ... TF1

NO.1 경제�?�털 :: 매�?�경제  -  Jul 17, 2008
...피부병 전문 글로벌 특수제약 회사�?� 갈�?�마 파마(Galderma Pharma SA)는 17�?� �?�본 �?� 후�? 노�?�성�?� 참신한 국소 여드름 치료제�?� Differin(R) Gel 0.1% (adapalene) ... 매�?�경제

Brand X needs muscle to stay ahead.(NAME THAT BRAND) | Article from …  -  Oct 1, 2007
Overall, Brand Pharm won four out of six new-business ... the Differin, MetroGel and Tri-Luma brands. Teva Pharmaceuticals tapped Brand Pharm for its ... Pay-Per-View - Medical Marketing & Media - HighBeam Research

Brand X gets organ-ized.(NAME THAT BRAND)(Brief article) | Article...  -  May 1, 2007
Brand X gets organ-ized.(NAME THAT BRAND)(Brief article) ... find Medical Marketing & Media articles. Professional ads for this fixed combo product, ... Pay-Per-View - Medical Marketing & Media - HighBeam Research

Brand X has got your back.(NAME THAT BRAND) | Article from Medical …  -  Feb 1, 2007
Brand X has got your back.(NAME THAT BRAND) ... find Medical Marketing & Media articles. Brand X, approved in May, is a breakthrough vaccine that promises ... Pay-Per-View - Medical Marketing & Media - HighBeam Research

Press Release: Galderma Completes Tender Offer for CollaGenex. - PR …  -  Apr 7, 2008
Galderma Completes Tender Offer for CollaGenex. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research

Brand X gives caged birds a new song.(NAME THAT BRAND) | Article …  -  Oct 1, 2008
Brand X gives caged birds a new song.(NAME THAT BRAND) ... find Medical Marketing & Media articles. [ILLUSTRATION OMITTED] Brand X uses a caged bird ... Pay-Per-View - Medical Marketing & Media - HighBeam Research

Y Brand.(AGENCIES) | Article from Medical Marketing & Media | …  -  Jun 1, 2008
Overall, Brand Pharm won four out of six new-business ... the Differin, MetroGel and Tri-Luma brands. Teva Pharmaceuticals tapped Brand Pharm for its ... Pay-Per-View - Medical Marketing & Media - HighBeam Research

The pen that rewrites the rules.(NAME THAT BRAND) | Article from …  -  Mar 1, 2007
The pen that rewrites the rules.(NAME THAT BRAND) ... find Medical Marketing & Media articles. This month's brand X aims to prove that the pen is mightier ... Pay-Per-View - Medical Marketing & Media - HighBeam Research

Brand X surpasses the seasons.(NAME THAT BRAND) | Article from …  -  Jan 1, 2008
Brand X surpasses the seasons.(NAME THAT BRAND) ... find Medical Marketing & Media articles. [ILLUSTRATION OMITTED] While this follow-on's predecessor ... Pay-Per-View - Medical Marketing & Media - HighBeam Research

Treatment of lentigo maligna with imiquimod 5% cream.(CASE REPORTS …  -  Oct 1, 2007
Lentigo maligna (LM) is an in situ melanoma that occurs in sun-damaged skin on the head and neck of elderly patients. Surgical excision is the treatment of ... $4.95 - Journal of Drugs in Dermatology - ECNext

Brand X is staying ahead of the pack.(NAME THAT BRAND) | Article from...  -  Sep 1, 2007
Brand X is staying ahead of the pack.(NAME THAT BRAND) ... find Medical Marketing & Media articles. Brand X isn't exactly running out the clock. Pay-Per-View - Medical Marketing & Media - HighBeam Research

Press Release: Galderma Announces HSR Clearance for Its Proposal to …  -  Mar 19, 2008
Galderma Announces HSR Clearance for Its Proposal to Acquire CollaGenex Pharmaceuticals. from PR Newswire Europe. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire Europe - HighBeam Research

Brand X aiming for even bigger sales.(NAME THAT BRAND) | Article from...  -  Dec 1, 2008
Brand X aiming for even bigger sales.(NAME THAT BRAND) ... find Medical Marketing & Media articles. [ILLUSTRATION OMITTED] This month's Brand X is the apple ... Pay-Per-View - Medical Marketing & Media - HighBeam Research

Pele - Manchas da gravidez podem ser diminuídas  -  Jun 29, 2005
O nome pode parecer estranho: melasma, mas, certamente, a maioria das pessoas já viu ou conhece algum portador da doença. É o caso da dona de casa Maria de ... Paraná-Online - Paraná-Online (Assinatura)

Anvisa suspende venda de creme clareador para pele  -  Jun 3, 2007
A Agência Nacional de Vigilância Sanitária (Anvisa) determinou a suspensão de importação e comercialização do creme Tri-Luma, medicamento usado para clarear ... Terra Brasil

勿需整容的护肤魔法(图)  -  Jan 19, 2006
Tri-Luma是一�?脱乳化剂�?对苯二酚(美白因�?)和�?�的�?�(防止皮肤刺激)的混�?�物。“ 它旨在对抗皱纹，摆脱黄�?斑和调和�?�?�匀的肤色。�?Martel说，“它是你能找到的最好的抗 ... 楚天都市报

Rostros manchados  -  Apr 22, 2005
El sol, los cambios hormonales y el factor genético están involucrados en la gestación de las antiestéticas manchas cafés que aparecen en la cara, ... La Nación - La Nación (Chile)

Galderma 完�?对CollaGenex 的收购  -  Apr 14, 2008
...新�?�美通瑞士洛桑4月14日电：专注于皮肤医学的全�?�性专业制�?��?业Galderma Pharma SA 今天宣布，该公�?�的美国控股公�?�Galderma Laboratories, Inc. 已完�?了 ... 金�?界

Galderma Tras 32% Más En Ventas  -  Jun 12, 2006
Se trata del suizo Galderma, que se especializa en productos para el tratamiento de enfermedades dermatológicas, el cual prevé incrementar sus ventas en un ... El Tiempo - El Tiempo (Colombia)

Especialistas afirmam que, apesar das muitas técnicas disponíveis,...  -  Jul 21, 2005
O melasma é uma doença da pele que sempre esteve associada à gravidez, sendo chamada de cloasma, ou máscara de grávida. Hoje, os dermatologistas já sabem ... Diário de Pernambuco

Galderma faz acordo para adquirir a CollaGenex Pharmaceuticals  -  Feb 28, 2008
Lausanne, Suíça e Newtown, Pensilvânia - A Galderma Pharma SA, uma empresa farmacêutica especializada global dedicada à dermatologia, ea CollaGenex ... Revista Fator

Galderma conclui oferta de compra da CollaGenex  -  Apr 8, 2008
Lausanne, Suíça - A Galderma Pharma SA, uma companhia farmacêutica global especializada, dedicada à dermatologia, anunciou no dia 7 de abril (segunda-feira) ... Revista Fator

Galderma Pharma SS et zars Pharma Inc. étendent au monde entier leur ...  -  Mar 7, 2008
Galderma Pharma SA et ZARS Pharma, Inc. ont conclu un nouvel accord octroyant à Galderma les droits exclusifs pour la promotion et la distribution sur tous ... LeLézard.com

COMUNICADO: Galderma finaliza su oferta de licitación sobre …  -  Apr 7, 2008
Galderma Pharma SA, una empresa farmacéutica especializada global dedicada a la dermatología, ha anunciado hoy que su compañía de holding de EE. ... elEconomista.es

COMUNICADO: Galderma Pharma, SA y ZARS Pharma, Inc. amplían su …  -  Mar 8, 2008
...-- Galderma Pharma, SA y ZARS Pharma, Inc. amplían su acuerdo para dar cobertura a los derechos mundiales de Pliaglis(TM). Galderma Pharma, SA ha anunciado ... elEconomista.es

COMUNICADO: Galderma llega a un acuerdo para adquirir CollaGenex …  -  Feb 27, 2008
Galderma Pharma SA, una compañía farmacéutica mundial especializada en dermatología, y CollaGenex Pharmaceuticals, Inc. (Nasdaq: CGPI) han anunciado hoy un ... elEconomista.es

Galderma finaliza a aquisição da CollaGenex  -  Apr 15, 2008
Lausanne, Suíça - A Galderma Pharma SA, uma companhia farmacêutica global especializada dedicada à dermatologia, anunciou que sua empresa controladora dos ... Revista Fator

COMUNICADO: Galderma Pharma, SA y ZARS Pharma, Inc. amplían su …  -  Aug 3, 2008
...-- Galderma Pharma, SA y ZARS Pharma, Inc. amplían su acuerdo para dar cobertura a los derechos mundiales de Pliaglis(TM). Galderma Pharma, SA ha anunciado ... Cotizalia.com

COMUNICADO: Galderma anuncia autorización de HSR para su …  -  Mar 20, 2008
Galderma Pharma SA, una empresa farmacéutica especializada global dedicada a la dermatología, ha anunciado hoy que su compañía tenedora estadounidense, ... elEconomista.es

Galderma fortalece su posición en Argentina  -  Sep 15, 2008
Laboratorios Galderma, especialista dermatología, fortalece su posición en el mercado argentino de la mano de importantes lanzamientos que le permitirán ... Asteriscos

Brand Names/Synonyms:
TRI-LUMA is also known by the following brand names and/or synonymsAberel; Accutane; Airol; Aknefug; Aknoten; All Trans Retinoic Acid; All Trans-Retinoic Acid; Amnesteem; Avita; Beta-Retinoic Acid; Claravis; Dermairol; Eudyna; Isotretinoin; Lsotretinoin; Panretin; Renova; Retin-A; Retin-a Micro; Retinoate; Retinoic Acid; Retinoic Acid, All Trans Isomer; Retionic Acid; Retisol-A; Solage; Sotret; Stieva-A; Stieva-a Forte; Trans-Retinoic Acid; Tretin M; Tretinoin; Tri-Luma; Vesanoid; Vitamin a Acid; Vitinoin; β-Retinoic Acid

Drug Category:
TRI-LUMA is categorized under the following by the FDA: Keratolytic Agents; Antineoplastic Agents; Cell Stimulants and Proliferants (84:16.00); ATC:D10AD01; ATC:D10AD04; ATC:D10BA01; ATC:L01XX14; ATC:L01XX22

Dosage Forms:
CAPSULE; CREAM; GEL; LIQUID

Absorption:
1-31% (topical);

Interactions:
[an error occurred while processing this directive]

Chemical IUPAC Name:
3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)-nona-2,4,6,8-tetraenoic acid

Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.